Bill Snyder Archive — Page 85 of 119

April 7, 2016

Purdue’s Low set for next Flexner Discovery Lecture

Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14.

By Bill Snyder
DNA sequence visualization
April 4, 2016

VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

By Bill Snyder
March 24, 2016

Nobel laureate Lefkowitz set for next Discovery Lecture

Robert Lefkowitz, M.D., who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on March 31.

By Bill Snyder
alarm clock
March 17, 2016

Study suggests cancer’s ‘clock’ can be rewound

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.

By Bill Snyder
March 17, 2016

Research Staff Awards honor contributions to discovery

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 12th annual Research Staff Awards luncheon at the University Club.

By Bill Snyder
March 17, 2016

Study explores gene’s role in protecting HIV patients from TB

An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.

By Bill Snyder